Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kast

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Contemporary Oncology (Poznan, Poland)|June 3, 2015
Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancersRichard E Kast
Biomedicines|March 28, 2025
UBC4: A Repurposed Drug Regimen for Adjunctive Use During Bladder Cancer TreatmentRichard E Kast
Medical Sciences (Basel, Switzerland)|March 6, 2021
Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma ChemoirradiationRichard E Kast
Oncology Research|June 24, 2009
Endothelin-1 inhibition by ambrisentan as a potential treatment adjunct after debulking surgery in epithelial ovarian cancerR E Kast
Anesthesia Progress|October 29, 2005
Tiagabine may reduce bruxism and associated temporomandibular joint painR E Kast
Journal of Neuroscience Research|July 16, 2008
Minocycline in cerebral malariaRichard E Kast
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 7, 2000
Non-steroidal anti-inflammatory drugs might also be pro-inflammatory by increasing tumor necrosis factorR E Kast
International Journal of Immunopharmacology|November 25, 2000
Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMPR E Kast
Yonsei Medical Journal|April 28, 2006
Evidence that amphotericin B mediates reactivation of latent Epstein-Barr virus in Hodgkin's lymphoma allowing cytotoxicity by acyclovirRichard E Kast
Medical Hypotheses|January 1, 1980
Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected dataR E Kast
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Contemporary Oncology (Poznan, Poland)|June 3, 2015
Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancersRichard E Kast
Biomedicines|March 28, 2025
UBC4: A Repurposed Drug Regimen for Adjunctive Use During Bladder Cancer TreatmentRichard E Kast
Medical Sciences (Basel, Switzerland)|March 6, 2021
Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma ChemoirradiationRichard E Kast
Oncology Research|June 24, 2009
Endothelin-1 inhibition by ambrisentan as a potential treatment adjunct after debulking surgery in epithelial ovarian cancerR E Kast
Anesthesia Progress|October 29, 2005
Tiagabine may reduce bruxism and associated temporomandibular joint painR E Kast
Journal of Neuroscience Research|July 16, 2008
Minocycline in cerebral malariaRichard E Kast
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 7, 2000
Non-steroidal anti-inflammatory drugs might also be pro-inflammatory by increasing tumor necrosis factorR E Kast
International Journal of Immunopharmacology|November 25, 2000
Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMPR E Kast
Yonsei Medical Journal|April 28, 2006
Evidence that amphotericin B mediates reactivation of latent Epstein-Barr virus in Hodgkin's lymphoma allowing cytotoxicity by acyclovirRichard E Kast
Medical Hypotheses|January 1, 1980
Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected dataR E Kast
Pageof 18